211 related articles for article (PubMed ID: 9511036)
1. In-vitro selection of resistance to vancomycin and teicoplanin in Enterococcus faecium and Enterococcus faecalis compared with Staphylococcus epidermidis.
Markopulos E; Graninger W; Georgopoulos A
J Antimicrob Chemother; 1998 Jan; 41(1):43-7. PubMed ID: 9511036
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of vancomycin-resistant Enterococcus spp. clinical isolates recovered from hospitalized patients among several medical institutions in China.
Sun H; Wang H; Xu Y; Jones RN; Costello AJ; Liu Y; Li G; Chen M; Mendes RE
Diagn Microbiol Infect Dis; 2012 Dec; 74(4):399-403. PubMed ID: 23099304
[TBL] [Abstract][Full Text] [Related]
3. Resistance of enterococci to ampicillin and glycopeptide antibiotics in Italy. The Italian Surveillance Group for Antimicrobial Resistance.
Fontana R; Ligozzi M; Mazzariol A; Veneri G; Cornaglia G
Clin Infect Dis; 1998 Aug; 27 Suppl 1():S84-6. PubMed ID: 9710675
[TBL] [Abstract][Full Text] [Related]
4. In vitro studies of the pharmacodynamics of teicoplanin against Staphylococcus aureus, Staphylococcus epidermidis and Enterococcus faecium.
Odenholt I; Löwdin E; Cars O
Clin Microbiol Infect; 2003 Sep; 9(9):930-7. PubMed ID: 14616681
[TBL] [Abstract][Full Text] [Related]
5. [Vancomycin resistance among strains of Enterococcus faecium].
Sacha P; Wieczorek P; Jakoniuk P
Przegl Lek; 2008; 65(5):229-32. PubMed ID: 18853647
[TBL] [Abstract][Full Text] [Related]
6. European Glycopeptide Susceptibility Survey of gram-positive bacteria for 1995. European Glycopeptide Resistance Survey Study Group.
Felmingham D; Brown DF; Soussy CJ
Diagn Microbiol Infect Dis; 1998 Aug; 31(4):563-71. PubMed ID: 9764397
[TBL] [Abstract][Full Text] [Related]
7. A comparative in-vitro evaluation of resistance selection after exposure to teicoplanin, vancomycin, linezolid and quinupristin-dalfopristin in Staphylococcus aureus and Enterococcus spp.
Drago L; Nicola L; De Vecchi E
Clin Microbiol Infect; 2008 Jun; 14(6):608-11. PubMed ID: 18397336
[TBL] [Abstract][Full Text] [Related]
8. A gene conferring resistance to vancomycin but not teicoplanin in isolates of Enterococcus faecalis and Enterococcus faecium demonstrates homology with vanB, vanA, and vanC genes of enterococci.
Gold HS; Unal S; Cercenado E; Thauvin-Eliopoulos C; Eliopoulos GM; Wennersten CB; Moellering RC
Antimicrob Agents Chemother; 1993 Aug; 37(8):1604-9. PubMed ID: 8215270
[TBL] [Abstract][Full Text] [Related]
9. Molecular Epidemiology of Vancomycin-Resistant Enterococcus faecalis and Enterococcus faecium Isolated from Clinical Specimens in the Northwest of Iran.
Jahansepas A; Ahangarzadeh Rezaee M; Hasani A; Sharifi Y; Rahnamaye Farzami M; Dolatyar A; Aghazadeh M
Microb Drug Resist; 2018 Oct; 24(8):1165-1173. PubMed ID: 29708837
[TBL] [Abstract][Full Text] [Related]
10. Occurrence of vancomycin-resistant enterococci in relation to the administration of glycopeptide antibiotics.
Kolár M; Vágnerová I; Látal T; Kohnová I
Acta Univ Palacki Olomuc Fac Med; 1999; 142():69-71. PubMed ID: 10743728
[TBL] [Abstract][Full Text] [Related]
11. In vitro stepwise selection of reduced susceptibility to lipoglycopeptides in enterococci.
Arhin FF; Seguin DL; Belley A; Moeck G
Diagn Microbiol Infect Dis; 2017 Oct; 89(2):168-171. PubMed ID: 28733126
[TBL] [Abstract][Full Text] [Related]
12. The in-vitro activity of LY333328, a new glycopeptide, against clinical isolates of vancomycin-resistant enterococci.
Kirk M; Hill RL; Casewell MW; Beighton D
Adv Exp Med Biol; 1997; 418():483-5. PubMed ID: 9331699
[No Abstract] [Full Text] [Related]
13. Time-kill study and synergistic activity of cell-wall inhibitor antibiotics in combination with gentamicin against Enterococcus faecalis and Enterococcus faecium.
Aligholi M; Emaneini M; Taherikalani M; Shahsavan S; Jabalameli F; Asadollahi P; Khoramian B; Eslampour MA
Acta Microbiol Immunol Hung; 2011 Sep; 58(3):219-26. PubMed ID: 21983323
[TBL] [Abstract][Full Text] [Related]
14. [Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine].
Rudy M; Nowakowska M; Wiechuła B; Zientara M; Radosz-Komoniewska H
Przegl Lek; 2004; 61(5):473-6. PubMed ID: 15515808
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility of staphylococci and enterococci to glycopeptides comparison of 3 test methods.
Jansen B; Schumacher-Perdreau F; Pulverer G
Zentralbl Bakteriol; 1995 Oct; 282(4):402-8. PubMed ID: 9810663
[TBL] [Abstract][Full Text] [Related]
16. Activity of a new glycopeptide antibiotic (LY333328) against enterococci and other resistant gram-positive organisms.
Fraise AP; Andrews J; Wise R
J Antimicrob Chemother; 1997 Sep; 40(3):423-5. PubMed ID: 9338497
[TBL] [Abstract][Full Text] [Related]
17. Glycopeptide resistance in Enterococcus spp. and coagulase-negative staphylococci from hospitalised patients in Germany: occurrence, characteristics and dalbavancin susceptibility.
Kresken M; Klare I; Wichelhaus TA; Wohlfarth E; Layer-Nicolaou F; Neumann B; Werner G;
J Glob Antimicrob Resist; 2022 Mar; 28():102-107. PubMed ID: 34958996
[TBL] [Abstract][Full Text] [Related]
18. In vivo development of teicoplanin resistance in a VanB Enterococcus faecium isolate.
Hayden MK; Trenholme GM; Schultz JE; Sahm DF
J Infect Dis; 1993 May; 167(5):1224-7. PubMed ID: 8486959
[TBL] [Abstract][Full Text] [Related]
19. New combinations of mutations in VanD-Type vancomycin-resistant Enterococcus faecium, Enterococcus faecalis, and Enterococcus avium strains.
Depardieu F; Foucault ML; Bell J; Dubouix A; Guibert M; Lavigne JP; Levast M; Courvalin P
Antimicrob Agents Chemother; 2009 May; 53(5):1952-63. PubMed ID: 19258279
[TBL] [Abstract][Full Text] [Related]
20. Multidrug-resistant gram-positive pathogens. An update on current microbiological patterns.
Marchese A; Debbia EA; Bacca D; Balistreri G; Musolino B; Schito GC
Drugs; 1997; 54 Suppl 6():11-20. PubMed ID: 9474477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
